Insider Cluster (4 insiders) ·Filed May 20, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 4 insiders, $0.8M total
Actionable Insight • Neutral

Insider cluster sells after a $108M offering are routine and likely liquidity-driven (vesting/blackout window). The minimal dollar proportion (0.04% of market cap) does not support a bearish read-through. Monitor for any pipeline news or upcoming clinical data that may have motivated the sales, but for now treat this as noise.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +15.65% at T+60d
NEUTRAL call ✓ call won +15.65% · α vs SPY +11.35% · entry $30.54 → $35.32
Entry anchored
May 20, 2026
via day open
T+1d
-2.82%
call -2.82% · α -3.26%
$29.68
settled 4mo ago
T+5d
-1.24%
call -1.24% · α -3.09%
$30.16
settled 4mo ago
T+20d
+8.07%
call +8.07% · α +7.74%
$33.01
settled 4mo ago
T+60d
+15.65%
call +15.65% · α +11.35%
$35.32
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Four insiders at Pharvaris, including the CEO and Chief Commercial Officer, sold shares totaling $786K in open-market transactions over a 7-day window, closely following a $108M public offering completed on May 8. The cluster is predominantly selling, but the dollar amount is modest relative to the $2.0B market cap (~0.04%), and the asymmetric insider-selling literature indicates cluster sells are not reliably informative beyond the proportionality band. The cross-filing context with a recent offering is a known calibrative amplifier for this pattern, but the trivial proportionality keeps the signal low.

Key Financial Metrics

Direction
selling
Total Value
$786.0K
Insiders
4

Key Facts

  • Total insider sales: $786K across 4 insiders (CEO, CCO, CTO, Director)
  • Sales occurred between May 15 and May 18, 2026, at ~$29.20–$29.92 per share
  • CEO Berndt Modig sold 2,292 shares for $67K on May 18
  • The cluster follows a $108M public offering (424B5) that closed May 8, 2026
  • Sales represent ~0.04% of Pharvaris's $2.0B market cap
  • Both principal deliveries (non-cash derivative exercises) accompanied the Director's sale; aggregate net cash to insiders is $786K

Financial Impact

$786K in insider sales over 7 days; 0.04% of $2.0B market cap

insider ownershipfloat

Risk Factors

  • CEO selling even a small amount near $29 could indicate peak personal valuation if no later open-market purchases materialize
  • If subsequent insider filings show additional material sales by the CEO or CFO without buys, the signal would modestly intensify

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1779312846156
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 20, 2026